Table 1

Main clinical manifestations related to the APS that appeared during the 10-year follow-up (1999–2009) of the total cohort of 1000 patients

Clinical manifestation*0 year† (n=1000)
No. (%)
0–5 year (n=1000)
No. (%)
5–10 year (n=796)‡
No (%)
0–10 year (n=1000)
No (%)
Thrombocytopenia (<100 000/µL)296 (29.6)37 (3.7)50 (6.3)87 (8.7)
Livedo reticularis241 (24.1)26 (2.6)55 (6.9)81 (8.1)
Stroke198 (19.8)24 (2.4)29 (3.6)53 (5.3)
Transient ischaemic attacks111 (11.1)23 (2.3)24 (3.0)47 (4.7)
Deep vein thrombosis389 (38.9)21 (2.1)22 (2.7)43 (4.3)
Pulmonary embolism141 (14.1)21 (2.1)14 (1.7)35 (3.5)
Epilepsy70 (7.0)17 (1.7)15 (1.9)32 (3.2)
Skin ulcers55 (5.5)17 (1.7)14 (1.7)31 (3.1)
Valve thickening/dysfunction116 (11.6)17 (1.7)29 (3.6)46 (4.6)
Vegetations27 (2.7)14 (1.4)7 (0.9)21 (2.1)
Myocardial infarction55 (5.5)9 (0.9)10 (1.2)19 (1.9)
Superficial thrombophlebitis117 (11.7)9 (0.9)8 (1.0)17 (1.7)
Autoimmune haemolytic anaemia97 (9.7)9 (0.9)31 (3.9)40 (4.0)
Obstetric manifestation§(n=1580)(n=105)(n=83)(n=188)
Pre-eclampsia/eclampsia82 (5.2)8 (7.6)4 (4.8)12 (6.4)
Early pregnancy loss (<10 weeks)560 (35.4)18 (17.1)13 (15.7)31 (16.5)
Late pregnancy loss (≥10 weeks)267 (16.9)7 (6.7)2 (2.4)9 (4.8)
Live birth753 (47.6)80 (76.2)57 (68.7)137 (72.9)
 Live birth with prematurity¶80 (10.6)28 (35.0)38 (66.7)66 (48.2)
 Live birth with intrauterine growth restriction¶11 (1.5)11 (13.7)25 (43.8)36 (26.3)
  • *Some patients had several associated presenting manifestations.

  • †Cumulative clinical manifestations at baseline. Previous period: median 6 years.

  • ‡Number of patients that continued in the study in 2004.

  • §Obstetric manifestation related to number of pregnancy (n). Some women had more than one pregnancy.

  • ¶Percentage related to number of live births.